SCHEMBL25545019

SCHEMBL25545019

COc1ccc(-c2nc(Nc3ncc(-c4cccs4)cc3C(=O)O)sc2CC(C)C)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNFRSF1A P19438 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ PTGDR2 Q9Y5Y4 4/20 0.40
▸ GRIN1 Q05586 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ CACNA1B Q00975 1/20 0.38
▸ APBA1 Q02410 1/20 0.38
▸ MAPK8 P45983 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ CAMKK2 Q96RR4 1/20 0.38
▸ NEK2 P51955 1/20 0.38
▸ PDGFRB P09619 1/20 0.36
▸ PDGFRA P16234 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25545229 0.94 ALDH1A1 (0.40) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25545079 0.93 TNFRSF1A (0.37) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25545218 0.93 TNFRSF1A (0.39) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25545140 0.92 TNFRSF1A (0.36) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25545027 0.92 DHODH (0.39) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25545202 0.91 EGFR (0.36) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25545207 0.91 TNFRSF1A (0.38) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25545205 0.91 MCHR1 (0.36) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25560053 0.91 DHODH (0.37) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A
SCHEMBL25545275 0.90 MAPT (0.38) TNFRSF1AKDM4EMEN1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 TNFRSF1A 4288/4885KDM4E 710/4885MEN1 2104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback